Rising Pharma Q1-2026 supplier risk profile: 137 shipments, 18 suppliers, India-focused pharmaceutical imports.
Rising Pharma imported 137 shipments in Q1 2026 across 18 suppliers, with sourcing heavily concentrated in India (95% of shipments). The company's supply chain focuses on pharmaceutical products, primarily HS Chapter 30 classifications including medicinal compounds and preparations. Graviti Pharmaceuticals Private Ltd dominates as the top supplier with 55 shipments, followed by Unique Pharmaceutical Laboratories with 29 shipments.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Rising Pharma has one name matching against sanctions watchlists. No suppliers in the disclosed network have registered forced-labor exposure under UFLPA proximity screening.
18 distinct tier-1 suppliers in Q1 2026
| GRAVITI PHARMACEUTICALS PRIVATE LIM | India | 55 |
| UNIQUE PHARMACEUTICAL LABORATORIES | India | 29 |
| AUROBINDO PHARMA | India | 13 |
| M S ELYSIUM PHARMACEUTICALS | India | 11 |
| COHANCE LIFESCIENCES | India | 3 |
| M S COHANCE LIFESCIENCES FO | India | 3 |
| M S COHANCE LIFESCIENCES LIMITEDFLO | India | 3 |
| APL HEALTH CARE | India | 2 |
Share of Q1 2026 inbound shipments by source country
14 tier-2 + 17 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.